Clinical efficacy study of Meryton syrup on Menorrhagia

Evaluation of clinical efficacy and safety of Meryton Syrup in the treatment of Menorrhagia

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/08/020571

Enrollment

Registered

2019-08-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

Intervention1: Syrup Meryton: TEST DRUG, DOSE AND DURATION: Test Drug: Meryton Syrup Dose: 15 mL twice a day, after meal (Measuring cup will be provided along with test drug) Vehicle: Normal drinkin

Eligibility

Inclusion criteria

Inclusion criteria: Patients with menstrual cycle between 21-35 days with bleeding morein volume and for 7 days,with BMI between 18-30kg/m2.

Exclusion criteria

Exclusion criteria: Patients sufferinfg from kidney,liver or cardiac disease Patients having genitic problem,anotomical defect of reproductive organs Patients suffering from dysmenorrhoea, PID Patients under hormonal treatement

Design outcomes

Primary

Measure	Time frame
Primary outcomes will be normalization of menstrual cycles and hormonal levels.Timepoint: 3 months	—

Secondary

Measure	Time frame
Assessment of drug safety, patient compliance and patientâ??s quality of lifeTimepoint: 1 month	—

Countries

India

Contacts

Public ContactDrSuchetha Kumari

SDM College of Ayurveda

suchetha.sdm@gmail.com9448529574

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026